The Board of Directors of Sopharma AD (the “Company”) notifies that in connection with the Christmas Holiday the results for December 2012 will be published on 10 January 2013.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 29 November 2012 up to and including 5 December 2012 the Company bought 50861 own shares representing 0.039% of the share capital of the Company, to the total value of BGN 114901.31 on the Bulgarian Stock Exchange. The average price per share was BGN 2.26.

he Board of Directors of Sopharma AD (the “Company”) hereby notifies that on 21 December 2012 Sopharma AD received a notification of disclosure of shareholdings from Financial Consulting Company regarding the selling of 999 840 shares. After this transaction the share of Financial Consulting Company in the capital of Sopharma AD decreased below 15% to 14, 56 %.

The date of registration of the transaction with the Central Depository AD is 20 December 2012.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 20 December 2012 up to and including 2 January 2013 the Company bought 1700 own shares representing 0.0013% of the share capital of the Company, to the total value of BGN 3631.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.14.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The Board of Directors of Sopharma AD (the “Company”) notifies that for December 2012 Sopharma AD realized decrease of sales revenues of 13% compared to the same period of 2011, including 9% decrease of domestic sales and 17% decrease of export sales. 

During the past twelve months Sopharma AD recorded an increase of sales revenues of 0.4%, including 9% decrease of domestic sales and 5% increase of export sales compared to 2011.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 10 January 2012 up to and including 16 January 2013 the Company bought 1000 own shares representing 0.00076% of the share capital of the Company, to the total value of BGN 2100 on the Bulgarian Stock Exchange. The average price per share was BGN 2.10.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3490931, representing 2.64% of the share capital of the Company.

The Board of Directors of Sopharma AD (the “Company”) hereby notifies that on 23 January 2013 Sopharma AD received a notification of disclosure of shareholdings from Financial Consulting Company regarding the selling of 4 053 002 shares. After this transaction the share of Financial Consulting Company in the capital of Sopharma AD decreased below 10% to 9.62 %.

The date of registration of the transaction with the Central Depository AD is 23 January 2013.

The Board of Directors of Sopharma AD (the “Company”) hereby notifies that on 23 January 2013 Sopharma AD received a notification of disclosure of shareholdings from Donev Investments Holding AD regarding the purchasing of 2 982 666 shares. After this transaction the share of Donev Investments Holding AD in the capital of Sopharma AD increased above 25% to 26.78%.

The date of registration of the transaction with the Central Depository AD is 23 January 2013.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 17 January 2012 up to and including 23 January 2013 the Company bought 20763 own shares representing 0.016% of the share capital of the Company, to the total value of BGN 44605.9 on the Bulgarian Stock Exchange. The average price per share was BGN 2.15.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3511694, representing 2.66% of the share capital of the Company.

The Board of Directors of Sopharma AD (the “Company”) presents the Invitation and the materials for the Extraordinary General Meeting of shareholders of "Sopharma” AD, which shall take place on 28 February 2013 from 11.00 AM and, in the absence of a quorum - on 15 March 2013 from 11.00 AM in Sofia, "Iliensko shosee" No 16. The invitation has been registered in the Commercial Register under number 20130123144949.

Attachments:

1. Invitation to EGM;
2. Minutes of the meeting of the Board of Directors for the convening of EGM
3. Sample letter of attorney for EGM

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 24 January 2012 up to and including 30 January 2013 the Company bought 30477 own shares representing 0.023% of the share capital of the Company, to the total value of BGN 71646.72 on the Bulgarian Stock Exchange. The average price per share was BGN 2.35.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3542171, representing 2.68% of the share capital of the Company.